Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $52,938 | $51,166 | $49,455 | $48,052 |
| % Growth | 3.5% | 3.5% | 2.9% | – |
| Cost of Goods Sold | $16,398 | $16,340 | $15,962 | $16,174 |
| Gross Profit | $36,540 | $34,826 | $33,493 | $31,878 |
| % Margin | 69% | 68.1% | 67.7% | 66.3% |
| R&D Expenses | $7,238 | $6,842 | $6,096 | $6,551 |
| G&A Expenses | $21,148 | $18,782 | $18,673 | $20,223 |
| SG&A Expenses | $27,718 | $25,003 | $24,694 | $26,440 |
| Sales & Mktg Exp. | $6,570 | $6,221 | $6,021 | $6,217 |
| Other Operating Expenses | $0 | $0 | -$111 | -$82 |
| Operating Expenses | $34,956 | $31,845 | $30,790 | $32,991 |
| Operating Income | $1,584 | $2,981 | $2,703 | -$1,113 |
| % Margin | 3% | 5.8% | 5.5% | -2.3% |
| Other Income/Exp. Net | $874 | -$120 | $245 | $235 |
| Pre-Tax Income | $2,458 | $2,861 | $2,948 | -$878 |
| Tax Expense | $2,337 | $904 | $401 | -$117 |
| Net Income | $121 | $1,415 | $1,826 | -$539 |
| % Margin | 0.2% | 2.8% | 3.7% | -1.1% |
| EPS | 0.001 | 0.021 | 0.02 | -0.006 |
| % Growth | -93.8% | 6.6% | 430% | – |
| EPS Diluted | 0.001 | 0.015 | 0.014 | -0.006 |
| Weighted Avg Shares Out | 94,262 | 92,904 | 92,381 | 89,509 |
| Weighted Avg Shares Out Dil | 129,558 | 128,984 | 128,852 | 128,309 |
| Supplemental Information | – | – | – | – |
| Interest Income | $533 | $487 | $356 | $317 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $2,960 | $2,873 | $2,674 |
| EBITDA | $1,584 | $5,941 | $5,576 | $1,561 |
| % Margin | 3% | 11.6% | 11.3% | 3.2% |